Federal contract award
75N98020F00021
PRE-CLINICAL DIAGNOSIS OF ALZHEIMER'S DISEASE (AD) AND AD-RELATED DEMENTIAS (ADRD): HOW BIOMARKERS AND OTHER PRE-CLINICAL DIAGNOSTICS MAY CHANGE AD/ADRD RESEARCH AND CLINICAL CARE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH OLAO |
| NAICS | 541690 — Other Scientific and Technical Consulting Services |
| PSC | R799 — Other Management Support Services |
| Parent award / vehicle | 75N98018D00029 |
| Set-aside | Not reported |
| Pricing type | COST NO FEE |
| Obligations | $208.9K |
| Current contract value | $208.9K |
| Potential contract value / ceiling | $208.9K |
| Start date | Sep 15, 2020 |
| Current end date | Dec 31, 2021 |
| Potential end date | Dec 31, 2021 |
| Latest award activity | Mar 21, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Mar 21, 2025 | P00001 | $-81.4K | PRE-CLINICAL DIAGNOSIS OF ALZHEIMER'S DISEASE (AD) AND AD-RELATED DEMENTIAS (ADRD): HOW BIOMARKERS AND OTHER PRE-CLINICAL DIAGNOSTICS MAY CHANGE AD/ADRD RESEARCH AND CLINICAL CARE |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.